| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |